The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences

Rito Bergemann; Elizabeth Ackermann; Brett Monia; Andrew Shenker; Peter Dyck

doi:10.1186/1750-1172-10-S1-O22

The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences

Rito Bergemann, Elizabeth Ackermann, Brett Monia, Andrew Shenker, Peter Dyck

Neurology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1-2
Number of pages	2
Journal	Orphanet Journal of Rare Diseases
Volume	10
DOIs	https://doi.org/10.1186/1750-1172-10-S1-O22
State	Published - 2015

ASJC Scopus subject areas

Genetics(clinical)
Pharmacology (medical)

Access to Document

10.1186/1750-1172-10-S1-O22

Cite this

Bergemann, R., Ackermann, E., Monia, B., Shenker, A., & Dyck, P. (2015). The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences. Orphanet Journal of Rare Diseases, 10, 1-2. https://doi.org/10.1186/1750-1172-10-S1-O22

The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences. / Bergemann, Rito; Ackermann, Elizabeth; Monia, Brett et al.
In: Orphanet Journal of Rare Diseases, Vol. 10, 2015, p. 1-2.

Research output: Contribution to journal › Article › peer-review

Bergemann, R, Ackermann, E, Monia, B, Shenker, A & Dyck, P 2015, 'The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences', Orphanet Journal of Rare Diseases, vol. 10, pp. 1-2. https://doi.org/10.1186/1750-1172-10-S1-O22

Bergemann R, Ackermann E, Monia B, Shenker A, Dyck P. The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences. Orphanet Journal of Rare Diseases. 2015;10:1-2. doi: 10.1186/1750-1172-10-S1-O22

Bergemann, Rito ; Ackermann, Elizabeth ; Monia, Brett et al. / The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy : Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences. In: Orphanet Journal of Rare Diseases. 2015 ; Vol. 10. pp. 1-2.

@article{24b9dc2887ce493fbc8363f871640b5e,

title = "The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences",

author = "Rito Bergemann and Elizabeth Ackermann and Brett Monia and Andrew Shenker and Peter Dyck",

year = "2015",

doi = "10.1186/1750-1172-10-S1-O22",

language = "English (US)",

volume = "10",

pages = "1--2",

journal = "Orphanet Journal of Rare Diseases",

issn = "1750-1172",

publisher = "BioMed Central",

}

TY - JOUR

T1 - The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy

T2 - Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences

AU - Bergemann, Rito

AU - Ackermann, Elizabeth

AU - Monia, Brett

AU - Shenker, Andrew

AU - Dyck, Peter

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84992135215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992135215&partnerID=8YFLogxK

U2 - 10.1186/1750-1172-10-S1-O22

DO - 10.1186/1750-1172-10-S1-O22

M3 - Article

AN - SCOPUS:84992135215

SN - 1750-1172

VL - 10

SP - 1

EP - 2

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

ER -

The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this